175 related articles for article (PubMed ID: 28647556)
1. Synapsin I phosphorylation is dysregulated by beta-amyloid oligomers and restored by valproic acid.
Marsh J; Bagol SH; Williams RSB; Dickson G; Alifragis P
Neurobiol Dis; 2017 Oct; 106():63-75. PubMed ID: 28647556
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Effects of Ferruginol, Jatrophone, and Junicedric Acid Against Amyloid-β Injury in Hippocampal Neurons.
Zolezzi JM; Lindsay CB; Serrano FG; Ureta RC; Theoduloz C; Schmeda-Hirschmann G; Inestrosa NC
J Alzheimers Dis; 2018; 63(2):705-723. PubMed ID: 29660932
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent reversal of synaptic plasticity induced by physiological concentrations of oligomeric Aβ42: an early index of Alzheimer's disease.
Koppensteiner P; Trinchese F; Fà M; Puzzo D; Gulisano W; Yan S; Poussin A; Liu S; Orozco I; Dale E; Teich AF; Palmeri A; Ninan I; Boehm S; Arancio O
Sci Rep; 2016 Sep; 6():32553. PubMed ID: 27581852
[TBL] [Abstract][Full Text] [Related]
4. Aging Enables Ca2+ Overload and Apoptosis Induced by Amyloid-β Oligomers in Rat Hippocampal Neurons: Neuroprotection by Non-Steroidal Anti-Inflammatory Drugs and R-Flurbiprofen in Aging Neurons.
Calvo-Rodríguez M; García-Durillo M; Villalobos C; Núñez L
J Alzheimers Dis; 2016 Jul; 54(1):207-21. PubMed ID: 27447424
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid and its congener propylisopropylacetic acid reduced the amount of soluble amyloid-β oligomers released from 7PA2 cells.
Williams RSB; Bate C
Neuropharmacology; 2018 Jan; 128():54-62. PubMed ID: 28947378
[TBL] [Abstract][Full Text] [Related]
6. Gender difference in valproic acid-induced neuroprotective effects on APP/PS1 double transgenic mice modeling Alzheimer's disease.
Long Z; Zeng Q; Wang K; Sharma A; He G
Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):930-938. PubMed ID: 27614317
[TBL] [Abstract][Full Text] [Related]
7. eEF2K inhibition blocks Aβ42 neurotoxicity by promoting an NRF2 antioxidant response.
Jan A; Jansonius B; Delaidelli A; Somasekharan SP; Bhanshali F; Vandal M; Negri GL; Moerman D; MacKenzie I; Calon F; Hayden MR; Taubert S; Sorensen PH
Acta Neuropathol; 2017 Jan; 133(1):101-119. PubMed ID: 27752775
[TBL] [Abstract][Full Text] [Related]
8. An in vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling.
Williams RS; Bate C
Neuropharmacology; 2016 Feb; 101():566-75. PubMed ID: 26116815
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.
Willén K; Sroka A; Takahashi RH; Gouras GK
J Alzheimers Dis; 2017; 60(2):511-524. PubMed ID: 28869466
[TBL] [Abstract][Full Text] [Related]
10. Activated Bone Marrow-Derived Macrophages Eradicate Alzheimer's-Related Aβ
Li S; Hayden EY; Garcia VJ; Fuchs DT; Sheyn J; Daley DA; Rentsendorj A; Torbati T; Black KL; Rutishauser U; Teplow DB; Koronyo Y; Koronyo-Hamaoui M
Front Immunol; 2020; 11():49. PubMed ID: 32082319
[TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers.
Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST
J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone prevents amyloid-β oligomer-induced impairment of synapse formation and plasticity via increasing dendrite and spine mitochondrial number.
Xu S; Liu G; Bao X; Wu J; Li S; Zheng B; Anwyl R; Wang Q
J Alzheimers Dis; 2014; 39(2):239-51. PubMed ID: 24150104
[TBL] [Abstract][Full Text] [Related]
13. Aβ1-16 controls synaptic vesicle pools at excitatory synapses via cholinergic modulation of synapsin phosphorylation.
Anni D; Weiss EM; Guhathakurta D; Akdas YE; Klueva J; Zeitler S; Andres-Alonso M; Huth T; Fejtova A
Cell Mol Life Sci; 2021 Jun; 78(11):4973-4992. PubMed ID: 33864480
[TBL] [Abstract][Full Text] [Related]
14. Stabilized Low-n Amyloid-β Oligomers Induce Robust Novel Object Recognition Deficits Associated with Inflammatory, Synaptic, and GABAergic Dysfunction in the Rat.
Watremez W; Jackson J; Almari B; McLean SL; Grayson B; Neill JC; Fischer N; Allouche A; Koziel V; Pillot T; Harte MK
J Alzheimers Dis; 2018; 62(1):213-226. PubMed ID: 29439327
[TBL] [Abstract][Full Text] [Related]
15. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
[TBL] [Abstract][Full Text] [Related]
16. Autophagy-ERK1/2-Involved Disinhibition of Hippocampal Neurons Contributes to the Pre-Synaptic Toxicity Induced by Aβ42 Exposure.
Yin Y; Zhao Y; Han S; Zhang N; Chen H; Wang X
J Alzheimers Dis; 2017; 59(3):851-869. PubMed ID: 28697568
[TBL] [Abstract][Full Text] [Related]
17. Aβ42-mediated proteasome inhibition and associated tau pathology in hippocampus are governed by a lysosomal response involving cathepsin B: Evidence for protective crosstalk between protein clearance pathways.
Farizatto KLG; Ikonne US; Almeida MF; Ferrari MFR; Bahr BA
PLoS One; 2017; 12(8):e0182895. PubMed ID: 28797057
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin protects against Aβ-induced synaptotoxicity by increasing presynaptic activity in hippocampal neurons.
Ramírez AE; Pacheco CR; Aguayo LG; Opazo CM
Biochim Biophys Acta; 2014 Sep; 1842(9):1495-501. PubMed ID: 24794719
[TBL] [Abstract][Full Text] [Related]
19. Protection against β-amyloid-induced synaptic and memory impairments via altering β-amyloid assembly by bis(heptyl)-cognitin.
Chang L; Cui W; Yang Y; Xu S; Zhou W; Fu H; Hu S; Mak S; Hu J; Wang Q; Ma VP; Choi TC; Ma ED; Tao L; Pang Y; Rowan MJ; Anwyl R; Han Y; Wang Q
Sci Rep; 2015 Jul; 5():10256. PubMed ID: 26194093
[TBL] [Abstract][Full Text] [Related]
20. Soluble Oligomers Require a Ganglioside to Trigger Neuronal Calcium Overload.
Cascella R; Evangelisti E; Bigi A; Becatti M; Fiorillo C; Stefani M; Chiti F; Cecchi C
J Alzheimers Dis; 2017; 60(3):923-938. PubMed ID: 28922156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
